Novartis starts Phase 2 trial of Monte Rosa's MRT-6160 in Sjögren's diseaseSep 8Clinical readoutMonte Rosa Therapeutics, IncNovartis
Novartis roundup: ITP real-world data completed; three trials registered; Utah study terminatedSep 4Weekly roundup, 6 itemsDDY391inclisiran
Monte Rosa reports Q2 2026 results as MGD pipeline advances on three frontsAug 6Quarterly updateMonte Rosa Therapeutics, Inc
Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial resultsJul 31Weekly roundup, 6 itemsabelacimabDDY391
Sign inSign in